Alternatively, the horseracing industry could choose the more difficult path of action.
Paul Tonko
The Public Record
Paul David Tonko is an American politician serving as the U.S. Representative for New York's 20th congressional district since 2013. A member of the Democratic Party, Tonko has focused on various issues including healthcare, renewable energy, and infrastructure. He has been an advocate for policies aimed at addressing climate change and improving public health. Tonko previously served in the New York State Assembly from 1983 to 2007, where he held the position of Assembly Majority Leader from 2005 to 2007.
We must build on the momentum in Congress and the industry as a whole to ensure the safety of our athletes and increase the popularity, public confidence, and international competitiveness of the sport.
The most recent draft of the Horseracing Integrity Act was developed through a highly deliberative and bipartisan process and takes into consideration a diversity of perspectives from all parts of the industry.
Simply quenching them without addressing their root cause is incomplete and irresponsible.
I appreciate my colleague and friend, Representative Barr, for all the work that we have been able to do together with that input.
When can we actually expect results from this scheme? We have received countless promises from the industry for decades.
A national uniform medication program is not about creating more bureaucracy or regulation; rather it is about streamlining the current regulatory structure to ensure the safety of our athletes.
Today, we find ourselves at an inflection point with regard to the future of horseracing.
By advancing the Horseracing Integrity Act and placing the majestic equine athletes front and center, we can truly capture the imagination of the Nation.
I am a conservative who believes in federalism and states' rights, but I also understand that the Constitution gives Congress the power to regulate interstate commerce precisely for the purpose of eliminating these kinds of impediments to…
Climate science should inform Federal action. Science and research should guide us forward and be the foundation for our action.
This bill presents us a bipartisan opportunity to ensure the next generation of refrigerants are American-made.
Thank you very much. And we are indeed fortunate to have you here today because of your wealth of technical expertise on many issues before us.
I cannot remember a time when we had the United States Chamber of Commerce, the National Association of Manufacturers, and the Natural Resources Defense Council in complete agreement on anything.
American companies are global leaders in the development of HFC substitutes.
This bill truly fits that description. It addresses an environmental concern in a manner that will spur innovation and make U.S. manufacturers more globally competitive.
Today the subcommittee will examine H.R. 5544, the American Innovation and Manufacturing Leadership Act of 2020.
This framework will guarantee that consumers are protected during the transition.
The HFC phase-down will drive the creation of some 33,000 new United States manufacturing jobs.
I have introduced the bipartisan Mainstreaming Addiction Treatment Act with over 100 co-sponsors to do exactly that.
This bill would phase-down the production and consumption of HFCs over 15 years, limiting the production and consumption to 15 percent of baseline levels beginning in 2036.
GenX is a group of PFAS chemicals that have been a particular concern for several communities. Last year, the Energy and Commerce Committee heard testimony from a member of one of those communities, Emily Donovan, of the group Clean Cape…
As the designee of the gentlewoman from Michigan (Mrs. Lawrence), I rise to offer an amendment. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: At the end of section 2, add the following…





